Skip to main content
PMC home page
Gut logoLink to Gut
. 1999 May;44(5):698–703. doi: 10.1136/gut.44.5.698

Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis

B Bapat 1, H Noorani 1, Z Cohen 1, T Berk 1, A Mitri 1, B Gallie 1, K Pritzker 1, S Gallinger 1, A Detsky 1
PMCID: PMC1727488  PMID: 10205208

Abstract

BACKGROUND—Mutations of the APC gene cause familial adenomatous polyposis (FAP), a hereditary colorectal cancer predisposition syndrome. 
AIMS—To conduct a cost comparison analysis of predictive genetic testing versus conventional clinical screening for individuals at risk of inheriting FAP, using the perspective of a third party payer. 
METHODS—All direct health care costs for both screening strategies were measured according to time and motion, and the expected costs evaluated using a decision analysis model. 
RESULTS—The baseline analysis predicted that screening a prototype FAP family would cost $4975/£3109 by molecular testing and $8031/£5019 by clinical screening strategy, when family members were monitored with the same frequency of clinical surveillance (every two to three years). Sensitivity analyses revealed that the genetic testing approach is cost saving for key variables including the kindred size, the age of screening onset, and the cost of mutation identification in a proband. However, if the APC mutation carriers were monitored at an increased (annual) frequency, the cost of the genetic screening strategy increased to $7483/£4677 and was especially sensitive to variability in age of onset of screening, family size, and cost of genetic testing of at risk relatives. 
CONCLUSIONS—In FAP kindreds, a predictive genetic testing strategy costs less than conventional clinical screening, provided that the frequency of surveillance is identical using either strategy. An additional significant benefit is the elimination of unnecessary colonic examinations for those family members found to be non-carriers. 



Keywords: familial adenomatous polyposis; adenomatous polyposis coli gene; cost analysis; genetic testing

Full Text

The Full Text of this article is available as a PDF (113.4 KB).

Figure 1 .

Figure 1

Open in a new tab

Decision model used in the cost comparison analysis of predictive genetic versus clinical screening strategy. The two options, genetic versus clinical screening, are indicated by the shaded square on the left. Each shaded circle represents chance events; rectangles on the extreme right represent outcomes corresponding to that path in the decision tree; *complementary probability. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bapat B. V., Parker J. A., Berk T., Cohen Z., McLeod R. S., Ray P. N., Stern H. S. Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines. Dis Colon Rectum. 1994 Feb;37(2):165–171. doi: 10.1007/BF02047541. [DOI] [PubMed] [Google Scholar]
  2. Belchetz L. A., Berk T., Bapat B. V., Cohen Z., Gallinger S. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1996 Apr;39(4):384–387. doi: 10.1007/BF02054051. [DOI] [PubMed] [Google Scholar]
  3. Burn J., Chapman P., Delhanty J., Wood C., Lalloo F., Cachon-Gonzalez M. B., Tsioupra K., Church W., Rhodes M., Gunn A. The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet. 1991 May;28(5):289–296. doi: 10.1136/jmg.28.5.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burt R. W., Groden J. The genetic and molecular diagnosis of adenomatous polyposis coli. Gastroenterology. 1993 Apr;104(4):1211–1214. doi: 10.1016/0016-5085(93)90297-p. [DOI] [PubMed] [Google Scholar]
  5. Béroud C., Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1996 Jan 1;24(1):121–124. doi: 10.1093/nar/24.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bülow S., Burn J., Neale K., Northover J., Vasen H. The establishment of a polyposis register. Int J Colorectal Dis. 1993 Mar;8(1):34–38. doi: 10.1007/BF00341274. [DOI] [PubMed] [Google Scholar]
  7. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991 Aug 9;66(3):589–600. doi: 10.1016/0092-8674(81)90021-0. [DOI] [PubMed] [Google Scholar]
  8. Jass J. R., Stewart S. M. Evolution of hereditary non-polyposis colorectal cancer. Gut. 1992 Jun;33(6):783–786. doi: 10.1136/gut.33.6.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Joslyn G., Carlson M., Thliveris A., Albertsen H., Gelbert L., Samowitz W., Groden J., Stevens J., Spirio L., Robertson M. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell. 1991 Aug 9;66(3):601–613. doi: 10.1016/0092-8674(81)90022-2. [DOI] [PubMed] [Google Scholar]
  10. Kassirer J. P., Moskowitz A. J., Lau J., Pauker S. G. Decision analysis: a progress report. Ann Intern Med. 1987 Feb;106(2):275–291. doi: 10.7326/0003-4819-106-2-275. [DOI] [PubMed] [Google Scholar]
  11. Kinzler K. W., Nilbert M. C., Su L. K., Vogelstein B., Bryan T. M., Levy D. B., Smith K. J., Preisinger A. C., Hedge P., McKechnie D. Identification of FAP locus genes from chromosome 5q21. Science. 1991 Aug 9;253(5020):661–665. doi: 10.1126/science.1651562. [DOI] [PubMed] [Google Scholar]
  12. Krahn M., Gafni A. Discounting in the economic evaluation of health care interventions. Med Care. 1993 May;31(5):403–418. doi: 10.1097/00005650-199305000-00003. [DOI] [PubMed] [Google Scholar]
  13. MacDonald F., Morton D. G., Rindl P. M., Haydon J., Cullen R., Gibson J., Neoptolemos J. P., Keighley M. R., McKeown C. M., Hultén M. Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based study. BMJ. 1992 Apr 4;304(6831):869–872. doi: 10.1136/bmj.304.6831.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mandl M., Paffenholz R., Friedl W., Caspari R., Sengteller M., Propping P. Frequency of common and novel inactivating APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet. 1994 Jan;3(1):181–184. doi: 10.1093/hmg/3.1.181. [DOI] [PubMed] [Google Scholar]
  15. Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med. 1974 Jun;67(6 Pt 1):451–457. [PMC free article] [PubMed] [Google Scholar]
  16. Nagase H., Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat. 1993;2(6):425–434. doi: 10.1002/humu.1380020602. [DOI] [PubMed] [Google Scholar]
  17. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991 Aug 9;253(5020):665–669. doi: 10.1126/science.1651563. [DOI] [PubMed] [Google Scholar]
  18. Pauker S. G., Kassirer J. P. The threshold approach to clinical decision making. N Engl J Med. 1980 May 15;302(20):1109–1117. doi: 10.1056/NEJM198005153022003. [DOI] [PubMed] [Google Scholar]
  19. Petersen G. M. Knowledge of the adenomatous polyposis coli gene and its clinical application. Ann Med. 1994 Jun;26(3):205–208. doi: 10.3109/07853899409147891. [DOI] [PubMed] [Google Scholar]
  20. Powell S. M., Petersen G. M., Krush A. J., Booker S., Jen J., Giardiello F. M., Hamilton S. R., Vogelstein B., Kinzler K. W. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med. 1993 Dec 30;329(27):1982–1987. doi: 10.1056/NEJM199312303292702. [DOI] [PubMed] [Google Scholar]
  21. Prosser J., Condie A., Wright M., Horn J. M., Fantes J. A., Wyllie A. H., Dunlop M. G. APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer. 1994 Nov;70(5):841–846. doi: 10.1038/bjc.1994.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rhodes M., Bradburn D. M. Overview of screening and management of familial adenomatous polyposis. Gut. 1992 Jan;33(1):125–131. doi: 10.1136/gut.33.1.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Richardson W. S., Detsky A. S. Users' guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1995 Apr 26;273(16):1292–1295. doi: 10.1001/jama.273.16.1292. [DOI] [PubMed] [Google Scholar]
  24. Richardson W. S., Detsky A. S. Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. JAMA. 1995 May 24;273(20):1610–1613. doi: 10.1001/jama.273.20.1610. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES